Guggenheim Capital’s AUXILIUM PHARAMCEUTICALS INC AUXL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-38,283
Closed -$1.32M 3143
2014
Q4
$1.32M Buy
38,283
+8,022
+27% +$262K ﹤0.01% 2045
2014
Q3
$904K Buy
30,261
+4,520
+18% +$95.8K ﹤0.01% 2292
2014
Q2
$516K Buy
25,741
+6,133
+31% +$141K ﹤0.01% 2586
2014
Q1
$533K Buy
+19,608
New +$521K ﹤0.01% 2558

Other funds holding AUXL

Guggenheim Capital's AUXL Position: Q1 2015 in Review

Guggenheim Capital sold out of AUXILIUM PHARAMCEUTICALS INC (AUXL) in Q1 2015, closing a stake of 38,283 shares — an estimated $1.32M sold.

Guggenheim Capital first reported a position in AUXL in Q1 2014 and held it in 4 quarters. The position peaked at $1.32M in Q4 2014. 1 fund tracked by Wall St. Rank holds AUXL as of Q1 2015.

  • Guggenheim Capital reported no remaining AUXILIUM PHARAMCEUTICALS INC position as of Q1 2015 after selling out during the quarter.
  • Guggenheim Capital sold 38,283 AUXILIUM PHARAMCEUTICALS INC shares in Q1 2015, an estimated $1.32M.
  • Guggenheim Capital first reported a position in AUXILIUM PHARAMCEUTICALS INC in Q1 2014 and held it in 4 quarters.
  • Guggenheim Capital's AUXILIUM PHARAMCEUTICALS INC position peaked at $1.32M in Q4 2014.
  • 1 fund tracked by Wall St. Rank held AUXILIUM PHARAMCEUTICALS INC as of Q1 2015.

Based on Guggenheim Capital's 13F filing for Q1 2015, filed 15 May 2015.